LAVA Therapeutics Appoints Dr. Charles Morris As Chief Medical Officer

RTTNews | 763天前
Stocktwits
LAVA Therapeutics Appoints Dr. Charles Morris As Chief Medical Officer

(RTTNews) - Immuno-oncology company LAVA Therapeutics N.V. (LVTX) announced Monday that Dr. Charles Morris has joined LAVA as chief medical officer effective February 6, 2023. Dr. Morris will replace Benjamin Winograd.

Dr. Morris is a medical oncologist with over 25 years of oncology drug development experience working with global biotech and pharmaceutical companies and managing numerous drug approvals.

Most recently, he was the chief medical officer for biotechnology company Celyad Oncology. He also served as chief medical officer of Radius Health and held leadership positions at PsiOxus Therapeutics, ImmunoGen and Allos Therapeutics.

He was also vice president of worldwide clinical research at Cephalon where he supported the approval of TREANDA (bendamustine) for the treatment of indolent non-Hodgkin lymphoma and chronic lymphocytopenia.

He began his career at AstraZeneca and held roles of increasing responsibility including global medical lead for Faslodex (fulvestrant) which he managed through its approval for breast cancer.

标签: LVTX
Stocktwits
read more
Dollar Tumbles As Trade War Ignites Growth Fears

Dollar Tumbles As Trade War Ignites Growth Fears

The U.S. dollar tumbled against major currencies during the week ended March 7 amidst an extended sell-off on Wall Street triggered by the escalation in the trade war and a weak labor market update.
RTTNews | 4小时45分钟前
Bay Street Likely To Open On Weak Note

Bay Street Likely To Open On Weak Note

Canadian shares are likely to open on a negative note Monday morning amid fears of a U.S. recession, and rising concerns about China's growth outlook.
RTTNews | 5小时10分钟前
Yen Rises Amid Risk Aversion

Yen Rises Amid Risk Aversion

The Japanese yen strengthened against other major currencies in the European session on Monday, as the investor sentiment fell on lingering tariff worries, the threat of a U.S. recession and signs of deepening deflationary pressures in China.
RTTNews | 6小时25分钟前
Yen Rises Against Majors

Yen Rises Against Majors

The Japanese yen strengthened against other major currencies in the European session on Tuesday.
RTTNews | 7小时30分钟前
FTSE 100 Slips After Positive Start, Down Nearly 0.6%

FTSE 100 Slips After Positive Start, Down Nearly 0.6%

After a positive start, U.K. stocks retreated Monday morning, with shares from banking sector recording notable losses. Concerns about the outlook for global economic growth and uncertainty about U.S. trade policy are hurting sentiment.
RTTNews | 7小时38分钟前
Sensex, Nifty Give Up Early Gains

Sensex, Nifty Give Up Early Gains

Indian shares ended slightly lower on Monday, failing to hold early gains due to uncertainty surrounding U.S. tariffs and signs of deepening deflationary pressures in China.
RTTNews | 8小时2分钟前
CAC 40 Modestly Lower In Cautious Trade

CAC 40 Modestly Lower In Cautious Trade

French stocks are exhibiting weakness Monday morning with investors making cautious moves amid concerns about growth and international trade due to continued uncertainty about the policies of the Trump Administration.
RTTNews | 8小时5分钟前
工具
经济日历
Market Hours
Interest Rates
Holidays Calendar
外汇市场
外汇波动率
外汇相关性
外汇新闻
forex analysis
COT数据
流动性
外汇计算器
外汇热力图
Indicators Heatmap
社区
社区
系统
最受欢迎的系统
策略
竞赛
外汇图表
外汇情绪
展望指标
评论
经纪人
Prop Trading Firms
VPS服务
信号提供者
EA编程服务
Affiliate Programs
PAMM经纪人服务
返利计划服务
交易平台
专家顾问
加密货币交易所
Trading Courses
经纪人
外汇点差
外汇经纪商报价
外汇经纪商掉期
外汇经纪商交易量
外汇经纪商促销 Press Release
平台
小工具
功能
API
RSS
Stock Portfolio
Affiliate Software
高级图表
支持
常见问题
帮助
联系我们
报告一个错误！
关于我们
博客
© 2025 Myfxbook Ltd. All Rights Reserved.
高风险警告：外汇交易具有高风险，可能不适合所有投资者。 杠杆创造了额外的风险和损失风险。 在您决定进行外汇交易之前，仔细考虑您的投资目标、经验水平和风险承受能力。 您可能会损失部分或全部的初始投资。不要投资您无法承受损失的钱。 对自己进行与外汇交易有关的风险教育，如果您有任何问题，请向独立的财务或税务顾问咨询。 任何数据和信息都是"按原样"提供的，仅仅是为了提供信息，并不打算用于交易目的或建议。 过去的业绩并不代表未来的结果。